Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes

Shima Ghoroghi(Inserm), Benjamin Mary(Inserm), Annabel Larnicol(Inserm), Nandini Asokan(Inserm), Annick Klein(Inserm), Naël Osmani(Inserm), Ignacio Busnelli(Inserm), François Delalande(Centre National de la Recherche Scientifique), Nicodème Paul(Inserm), Sébastien Halary(Centre National de la Recherche Scientifique), Frédéric Gros(Inserm), Laëtitia Fouillen(Centre National de la Recherche Scientifique), Anne‐Marie Haeberlé(Institut des Neurosciences Cellulaires et Intégratives), Cathy Royer(Centre National de la Recherche Scientifique), Coralie Spiegelhalter(Centre National de la Recherche Scientifique), Gwennan André‐Grégoire(Centre National de la Recherche Scientifique), Vincent Mittelheisser(Inserm), Alexandre Detappe(Centre National de la Recherche Scientifique), Kendelle J. Murphy(Garvan Institute of Medical Research), Paul Timpson(Garvan Institute of Medical Research), Raphaël Carapito(Inserm), Marcel Blot‐Chabaud(Inserm), Julie Gavard(Centre National de la Recherche Scientifique), Christine Carapito(Centre National de la Recherche Scientifique), Nicolas Vitale(Institut des Neurosciences Cellulaires et Intégratives), Olivier Lefèbvre(Inserm), Jacky G. Goetz(Inserm), Vincent Hyenne(Centre National de la Recherche Scientifique)
eLife
January 6, 2021
Cited by 123Open Access
Full Text

Abstract

Cancer extracellular vesicles (EVs) shuttle at distance and fertilize pre-metastatic niches facilitating subsequent seeding by tumor cells. However, the link between EV secretion mechanisms and their capacity to form pre-metastatic niches remains obscure. Using mouse models, we show that GTPases of the Ral family control, through the phospholipase D1, multi-vesicular bodies homeostasis and tune the biogenesis and secretion of pro-metastatic EVs. Importantly, EVs from RalA or RalB depleted cells have limited organotropic capacities in vivo and are less efficient in promoting metastasis. RalA and RalB reduce the EV levels of the adhesion molecule MCAM/CD146, which favors EV-mediated metastasis by allowing EVs targeting to the lungs. Finally, RalA, RalB, and MCAM/CD146, are factors of poor prognosis in breast cancer patients. Altogether, our study identifies RalGTPases as central molecules linking the mechanisms of EVs secretion and cargo loading to their capacity to disseminate and induce pre-metastatic niches in a CD146-dependent manner.


Related Papers

No related papers found

Powered by citation graph analysis